1. Home
  2. LUCY vs MRKR Comparison

LUCY vs MRKR Comparison

Compare LUCY & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUCY
  • MRKR
  • Stock Information
  • Founded
  • LUCY 2017
  • MRKR N/A
  • Country
  • LUCY United States
  • MRKR United States
  • Employees
  • LUCY N/A
  • MRKR N/A
  • Industry
  • LUCY Ophthalmic Goods
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • LUCY Health Care
  • MRKR Health Care
  • Exchange
  • LUCY Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • LUCY 10.3M
  • MRKR 11.8M
  • IPO Year
  • LUCY 2022
  • MRKR N/A
  • Fundamental
  • Price
  • LUCY $1.78
  • MRKR $1.20
  • Analyst Decision
  • LUCY
  • MRKR Strong Buy
  • Analyst Count
  • LUCY 0
  • MRKR 3
  • Target Price
  • LUCY N/A
  • MRKR $13.17
  • AVG Volume (30 Days)
  • LUCY 1.0M
  • MRKR 38.3K
  • Earning Date
  • LUCY 05-20-2025
  • MRKR 05-19-2025
  • Dividend Yield
  • LUCY N/A
  • MRKR N/A
  • EPS Growth
  • LUCY N/A
  • MRKR N/A
  • EPS
  • LUCY N/A
  • MRKR N/A
  • Revenue
  • LUCY $1,636,440.00
  • MRKR $6,591,080.00
  • Revenue This Year
  • LUCY $542.00
  • MRKR N/A
  • Revenue Next Year
  • LUCY $148.54
  • MRKR N/A
  • P/E Ratio
  • LUCY N/A
  • MRKR N/A
  • Revenue Growth
  • LUCY 41.99
  • MRKR 99.06
  • 52 Week Low
  • LUCY $1.57
  • MRKR $0.95
  • 52 Week High
  • LUCY $27.20
  • MRKR $5.99
  • Technical
  • Relative Strength Index (RSI)
  • LUCY 41.79
  • MRKR 50.23
  • Support Level
  • LUCY $1.70
  • MRKR $1.10
  • Resistance Level
  • LUCY $1.85
  • MRKR $1.29
  • Average True Range (ATR)
  • LUCY 0.20
  • MRKR 0.08
  • MACD
  • LUCY 0.05
  • MRKR 0.01
  • Stochastic Oscillator
  • LUCY 20.11
  • MRKR 58.10

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: